Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests cerebellar magnetic stimulation for thinking and mood problems

Tests magnetic stimulation of the cerebellum in adults with several brain and mood conditions.

Plain-language title generated from the registry record
Registry title: Cerebellar Stimulation and Cognitive Control

Key facts

Where
Iowa City, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 90 years old?

Source: NCT03217110, who can take part

Where in United States

  • University of IowaIowa City, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Krystal Parker, PhD
Trial code
NCT03217110
Record updated
19 March 2026
Original description
The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.Read full original descriptionShow less

Cerebellar Transcranial Magnetic Stimulation and Cognitive Control

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.

Inclusion: A clinical diagnosis consistent with enrollment.

Exclusion: History of recurrent seizures or epilepsy; Any other neurological or psychiatric diagnosis outside the diagnosis for which the participant is enrolled; Active substance use disorder in the past 6 months other than tobacco use disorder; Significant heart disease; Kidney disease; Inability to consent for study; Pacemaker; Coronary Stent; Defibrillator; Neurostimulation; Claustrophobia; Uncontrolled high blood pressure; Atrial fibrillation; Hemodynamic instability; Pregnant, trying to become pregnant, or breast feeding.

ClinicalTrials.gov NCT03217110